Brazil Healthcare Market Outlook 2020
Brazil is considered as one of the most lucrative healthcare market in Latin America, with consistent ranking amongst the top five global destinations for medical tourism. The country attracts a variety of medical tourists to take advantage of the successful and world-renowned cosmetic surgery industry. Growing demand for private healthcare has helped fuel a boom in the sector, which remains dominated by local players and has recently witnessed a number of mergers as many seek to capitalize on higher demand and consolidate their positions.
According to our report, “Brazil Healthcare Market Outlook 2020”, with better standards of living, the healthcare expenditure in the country has been rising continuously which is driving the healthcare industry. Among the healthcare sectors, the pharmaceutical market in the country witnessed tremendous growth, especially Prescription drugs market that enjoyed lion’s share of nearly 50% in 2015. However, the generics drug segment is forecasted to do well in future. With several factors, such as increasing patent expiries and greater generic company involvement in Brazil, the segment is anticipated to be the main factor for growth of the pharmaceutical market in the country. Besides, innovation and improvements in the medical equipment sector have been consistent in Brazil.
Healthcare spending in the country is anticipated to grow at a CAGR of around 5.8% during 2016-2020. The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country, like hypertension. Other major prevalent diseases covered in the report include cancer, tuberculosis, obesity and diabetes.
As per our findings, the future outlook of Brazil healthcare IT-industry is quite optimistic as the IT segment has witnessed significant mergers and acquisition in 2015. The world’s leading healthcare IT companies are also looking towards Brazil as an ideal destination for their business expansion. Brazil passed a new law allowing foreign companies to invest capital in private hospitals for the first time, a move expected to appeal to those eager to capitalize on high demand for private healthcare in the country, and bring much-needed funding to the sector. Investors from all over the globe are eager to invest in the country’s healthcare sector. For instance, India based drugmaker, Lupin, has acquired Medquímica Indústria Farmacêutica, a Brazilian branded generics and OTC maker, expanding its presence in Latin America through Brazil.
Our report provides an in-depth research and analysis of the key segments, namely Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, Healthcare IT industry, and other emerging market segments. It also highlights the current industry trends; presenting the key driver and foreign investments to enable clients understand the market structure and its prospective during the forecasted period. The report also covers detailed information about the active market players in hospital services, pharmaceutical, medical devices and healthcare IT-sector.
According to our report, “Brazil Healthcare Market Outlook 2020”, with better standards of living, the healthcare expenditure in the country has been rising continuously which is driving the healthcare industry. Among the healthcare sectors, the pharmaceutical market in the country witnessed tremendous growth, especially Prescription drugs market that enjoyed lion’s share of nearly 50% in 2015. However, the generics drug segment is forecasted to do well in future. With several factors, such as increasing patent expiries and greater generic company involvement in Brazil, the segment is anticipated to be the main factor for growth of the pharmaceutical market in the country. Besides, innovation and improvements in the medical equipment sector have been consistent in Brazil.
Healthcare spending in the country is anticipated to grow at a CAGR of around 5.8% during 2016-2020. The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country, like hypertension. Other major prevalent diseases covered in the report include cancer, tuberculosis, obesity and diabetes.
As per our findings, the future outlook of Brazil healthcare IT-industry is quite optimistic as the IT segment has witnessed significant mergers and acquisition in 2015. The world’s leading healthcare IT companies are also looking towards Brazil as an ideal destination for their business expansion. Brazil passed a new law allowing foreign companies to invest capital in private hospitals for the first time, a move expected to appeal to those eager to capitalize on high demand for private healthcare in the country, and bring much-needed funding to the sector. Investors from all over the globe are eager to invest in the country’s healthcare sector. For instance, India based drugmaker, Lupin, has acquired Medquímica Indústria Farmacêutica, a Brazilian branded generics and OTC maker, expanding its presence in Latin America through Brazil.
Our report provides an in-depth research and analysis of the key segments, namely Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, Healthcare IT industry, and other emerging market segments. It also highlights the current industry trends; presenting the key driver and foreign investments to enable clients understand the market structure and its prospective during the forecasted period. The report also covers detailed information about the active market players in hospital services, pharmaceutical, medical devices and healthcare IT-sector.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. HEALTHCARE MARKET OVERVIEW
4. MARKET TRENDS AND DRIVERS
4.1 Favorable Demographics
4.2 Epidemiology
4.2.1 Tuberculosis
4.2.2 Hypertension
4.2.3 Obesity
4.2.4 Diabetes
4.2.5 Cancer
4.3 Healthcare industry accelerated by Merger and Acquisition
4.4 Increased IT Penetration in Healthcare Industry
5. HEALTHCARE INDUSTRY OUTLOOK TO 2020
5.1 Healthcare Infrastructure
5.1.1 Hospitals
5.1.2 Beds
5.1.3 Human Resource
5.2 Pharmaceutical Market
5.2.1 Prescription Drug
5.2.2 Generic Drugs
5.2.3 OTC Drugs
5.2.4 Import and Export
5.3 Medical Equipment Industry
5.4 Healthcare IT-Market
5.4.1 E-health
5.4.2 M-health
5.4.3 Telemedicine
5.4.4 Medical Imaging Information System
6. MARKET OPPORTUNITIES
6.1 Health Insurance Industry
6.2 Medical Tourism Industry
6.3 Clinical Trials Industry
6.4 Biotech Industry
7. REGULATORY ENVIRONMENT
8. GOVERNMENT HEALTHCARE PROGRAMS
9. COMPETITIVE LANDSCAPE
9.1 Hospital Services
9.1.1 Group Hospital Conceição (GHC)
9.1.2 Rede D'Or Ltda.
9.1.3 The Albert Einstein Israeli Hospital (HIAE)
9.1.4 Universidade Federal do Maranhão (UFMA)
9.2 Pharmaceuticals
9.2.1 Sanofi-Aventis
9.2.2 Bayer
9.2.3 Novartis
9.2.4 Pfizer
9.3 Medical Equipment
9.3.1 GE Healthcare
9.3.2 Philips Healthcare
9.3.3 Air Liquide
9.3.4 Baxter
9.4 Healthcare IT
9.4.1 Agfa HealthCare
9.4.2 MV Sistemas
9.4.3 Wheb Sistemas SA
9.4.4 TOTVS
2. RESEARCH METHODOLOGY
3. HEALTHCARE MARKET OVERVIEW
4. MARKET TRENDS AND DRIVERS
4.1 Favorable Demographics
4.2 Epidemiology
4.2.1 Tuberculosis
4.2.2 Hypertension
4.2.3 Obesity
4.2.4 Diabetes
4.2.5 Cancer
4.3 Healthcare industry accelerated by Merger and Acquisition
4.4 Increased IT Penetration in Healthcare Industry
5. HEALTHCARE INDUSTRY OUTLOOK TO 2020
5.1 Healthcare Infrastructure
5.1.1 Hospitals
5.1.2 Beds
5.1.3 Human Resource
5.2 Pharmaceutical Market
5.2.1 Prescription Drug
5.2.2 Generic Drugs
5.2.3 OTC Drugs
5.2.4 Import and Export
5.3 Medical Equipment Industry
5.4 Healthcare IT-Market
5.4.1 E-health
5.4.2 M-health
5.4.3 Telemedicine
5.4.4 Medical Imaging Information System
6. MARKET OPPORTUNITIES
6.1 Health Insurance Industry
6.2 Medical Tourism Industry
6.3 Clinical Trials Industry
6.4 Biotech Industry
7. REGULATORY ENVIRONMENT
8. GOVERNMENT HEALTHCARE PROGRAMS
9. COMPETITIVE LANDSCAPE
9.1 Hospital Services
9.1.1 Group Hospital Conceição (GHC)
9.1.2 Rede D'Or Ltda.
9.1.3 The Albert Einstein Israeli Hospital (HIAE)
9.1.4 Universidade Federal do Maranhão (UFMA)
9.2 Pharmaceuticals
9.2.1 Sanofi-Aventis
9.2.2 Bayer
9.2.3 Novartis
9.2.4 Pfizer
9.3 Medical Equipment
9.3.1 GE Healthcare
9.3.2 Philips Healthcare
9.3.3 Air Liquide
9.3.4 Baxter
9.4 Healthcare IT
9.4.1 Agfa HealthCare
9.4.2 MV Sistemas
9.4.3 Wheb Sistemas SA
9.4.4 TOTVS
LIST OF FIGURES:
Figure 3-1: Healthcare Expenditure (Billion US$), 2014-2020
Figure 3-2: Healthcare Spending Percentage of GDP in Comparison to Latin American Countries (2013)
Figure 4-1: Spending on Medicines by Age Group (%), 2015
Figure 4-2: Share of Different Diseases in Population (2015)
Figure 4-3: Percentage of Population Diagnosed with Hypertension (2011, 2015 & 2018)
Figure 4-4: Percentage of Population with Obesity (2011, 2015 & 2018)
Figure 4-5: Overweight Population by Gender (%), 2015
Figure 4-6: Percentage of Population with Diabetes (2011, 2015 & 2018)
Figure 5-1: Share of Public and Private Hospitals (2014)
Figure 5-2: Forecast for Share of Public and Private Hospitals (2020)
Figure 5-3: Number of Hospital Beds ('000), 2014-2020
Figure 5-4: Share of Public and Private Hospital Beds (2014)
Figure 5-5: Number of Doctors (‘000), 2014-2020
Figure 5-6: Number of Nurses (‘000), 2014-2020
Figure 5-7: Share of Brazilian Pharmaceutical Market in Latin America (2015)
Figure 5-8: Pharmaceutical Market (Billion BRL), 2014-2020
Figure 5-9: Pharmaceutical Market (Billion Units), 2014-2020
Figure 5-10: Pharmaceutical Market by Segment (%), 2015
Figure 5-11: Forecast for Pharmaceutical Market by Segment (%), 2020
Figure 5-12: Share of Domestic and Foreign Pharmaceutical Laboratories (2015)
Figure 5-13: Pharmaceutical Market by Region (%), 2015
Figure 5-14: Prescription Drug Market (Billion BRL), 2014-2020
Figure 5-15: Prescription Drug Market (Million Units), 2014-2020
Figure 5-16: Generic Drugs Market (Billion BRL), 2014-2020
Figure 5-17: Generic Drugs Market (Million Units), 2014-2020
Figure 5-18: OTC Drug Market (Billion US$), 2014-2020
Figure 5-19: OTC Drugs Market (Million Units), 2014-2020
Figure 5-20: Pharmaceutical Imports (Billion US$), 2010-2013
Figure 5-21: Pharmaceutical Exports (Billion US$), 2010-2013
Figure 5-22: Medical Equipment Market (Billion US$), 2014-2020
Figure 5-23: Medical Equipment Imports (Billion US$), 2011, 2013 & 2014
Figure 5-24: Medical Equipment Exports (Million US$), 2011 & 2013
Figure 5-25: Healthcare IT Market (Billion US$), 2014-2020
Figure 5-26: E-health Market (Million US$), 2014-2020
Figure 5-27: M-health Market (Million US$), 2014-2020
Figure 5-28: Telemedicine Market (Million US$), 2014-2020
Figure 5-29: Medical Imaging Information System Market (Million US$), 2014-2020
Figure 5-30: Picture Archiving and Communications Systems (PACS) Market (Million US$), 2014-2020
Figure 6-1: Private Health Insurance Net Premium (Billion BRL), 2011-2014
Figure 6-2: Number of Clinical Studies (2011-2015)
Figure 3-1: Healthcare Expenditure (Billion US$), 2014-2020
Figure 3-2: Healthcare Spending Percentage of GDP in Comparison to Latin American Countries (2013)
Figure 4-1: Spending on Medicines by Age Group (%), 2015
Figure 4-2: Share of Different Diseases in Population (2015)
Figure 4-3: Percentage of Population Diagnosed with Hypertension (2011, 2015 & 2018)
Figure 4-4: Percentage of Population with Obesity (2011, 2015 & 2018)
Figure 4-5: Overweight Population by Gender (%), 2015
Figure 4-6: Percentage of Population with Diabetes (2011, 2015 & 2018)
Figure 5-1: Share of Public and Private Hospitals (2014)
Figure 5-2: Forecast for Share of Public and Private Hospitals (2020)
Figure 5-3: Number of Hospital Beds ('000), 2014-2020
Figure 5-4: Share of Public and Private Hospital Beds (2014)
Figure 5-5: Number of Doctors (‘000), 2014-2020
Figure 5-6: Number of Nurses (‘000), 2014-2020
Figure 5-7: Share of Brazilian Pharmaceutical Market in Latin America (2015)
Figure 5-8: Pharmaceutical Market (Billion BRL), 2014-2020
Figure 5-9: Pharmaceutical Market (Billion Units), 2014-2020
Figure 5-10: Pharmaceutical Market by Segment (%), 2015
Figure 5-11: Forecast for Pharmaceutical Market by Segment (%), 2020
Figure 5-12: Share of Domestic and Foreign Pharmaceutical Laboratories (2015)
Figure 5-13: Pharmaceutical Market by Region (%), 2015
Figure 5-14: Prescription Drug Market (Billion BRL), 2014-2020
Figure 5-15: Prescription Drug Market (Million Units), 2014-2020
Figure 5-16: Generic Drugs Market (Billion BRL), 2014-2020
Figure 5-17: Generic Drugs Market (Million Units), 2014-2020
Figure 5-18: OTC Drug Market (Billion US$), 2014-2020
Figure 5-19: OTC Drugs Market (Million Units), 2014-2020
Figure 5-20: Pharmaceutical Imports (Billion US$), 2010-2013
Figure 5-21: Pharmaceutical Exports (Billion US$), 2010-2013
Figure 5-22: Medical Equipment Market (Billion US$), 2014-2020
Figure 5-23: Medical Equipment Imports (Billion US$), 2011, 2013 & 2014
Figure 5-24: Medical Equipment Exports (Million US$), 2011 & 2013
Figure 5-25: Healthcare IT Market (Billion US$), 2014-2020
Figure 5-26: E-health Market (Million US$), 2014-2020
Figure 5-27: M-health Market (Million US$), 2014-2020
Figure 5-28: Telemedicine Market (Million US$), 2014-2020
Figure 5-29: Medical Imaging Information System Market (Million US$), 2014-2020
Figure 5-30: Picture Archiving and Communications Systems (PACS) Market (Million US$), 2014-2020
Figure 6-1: Private Health Insurance Net Premium (Billion BRL), 2011-2014
Figure 6-2: Number of Clinical Studies (2011-2015)
LIST OF TABLES:
Table 4-1: Demographic Characteristics (2010-2016)
Table 5-1: Number of Healthcare Institutions (2014)
Table 5-2: Number of Public Hospital Network Working for SUS (2014)
Table 5-3: Share of Hospitals by Region (2014)
Table 5-4: Number of Doctors per Thousand Populations by Top Cities (2013)
Table 5-5: Market Share of Leading Pharmaceutical Companies (2013)
Table 5-6: Leading Drugs by Sales (Million US$), 2013
Table 5-7: Market Share of Leading Generic Drugs Companies (2013)
Table 8-1: Key Goals under Various Parts of UPA 24-hours Program
Table 4-1: Demographic Characteristics (2010-2016)
Table 5-1: Number of Healthcare Institutions (2014)
Table 5-2: Number of Public Hospital Network Working for SUS (2014)
Table 5-3: Share of Hospitals by Region (2014)
Table 5-4: Number of Doctors per Thousand Populations by Top Cities (2013)
Table 5-5: Market Share of Leading Pharmaceutical Companies (2013)
Table 5-6: Leading Drugs by Sales (Million US$), 2013
Table 5-7: Market Share of Leading Generic Drugs Companies (2013)
Table 8-1: Key Goals under Various Parts of UPA 24-hours Program
